International Patent Application for Duchenne Muscular Dystrophy Therapeutic Substance

As of March 10, 2021, we completed the international application (PCT application) for the patent (Japanese Patent Application No. 2020-41637) for the Duchenne muscular dystrophy therapeutic molecule (X-0112) to the Japan Patent Office.

  Be an investor

More Details

  Make a donation

More Details